Bharat Biotech on Monday launched what is claimed to be the world's first clinically proven typhoid conjugate vaccine, Typbar - TCV.
"This vaccine induces T-cell dependent response with much higher antibody levels providing a very high rate of immunity," Krishna M. Ella, CMD of Bharat Biotech, told newspersons here.
Source:
0 Comments